Investigating the effect of chest physiotherapy in the treatment of covid-19
- Conditions
- Investigating the effect of chest physiotherapy on the recovery of patients with covid-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20220815055703N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 52
Desire to participate in the study
The average severity of the disease based on the diagnosis of a doctor specializing in respiratory diseases
Hospitalization at the time of diagnosis
Not using other chest physiotherapy programs at the same time
Absence of underlying diseases such as cancer, cardiovascular diseases and diabetes
Patient alertness
Able to perform chest physiotherapy activities
Reluctance or refusal to participate in the study
Changing the level of severity of the disease from moderate to severe level of the disease
Having respiratory failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vital capacity (FEV2/FVC ratio). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Spirometry device.;Arterial blood gases include: (PaO2), (PaCO2), (SaO2), (PaO2/FiO2). Timepoint: Before starting the intervention and at the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Arterial blood test.
- Secondary Outcome Measures
Name Time Method Vital capacity Vital capacity (FEV2/FVC ratio). Timepoint: At the end of the third and sixth days after the intervention (physiotherapy). Method of measurement: Spirometry device.;Arterial blood gases include: (PaO2), (PaCO2), (SaO2), (PaO2/FiO2). Timepoint: At the end of the sixth day after the start of the intervention (physiotherapy). Method of measurement: Arterial blood test.